{
  "submitter" : "Reach",
  "model_relation" : "extension",
  "extracted_information" : {
    "interaction_type" : "transcribes",
    "negative_information" : false,
    "participant_b" : {
      "in_model" : true,
      "identifier" : "uniprot:P43630",
      "entity_text" : "KIR3DL2",
      "entity_type" : "gene"
    },
    "hypothesis_information" : false,
    "context" : {
      "TissueType" : [ "tissuelist:TS-0649" ],
      "Cellular_component" : [ "uniprot:SL-0487" ],
      "Organ" : [ "uberon:UBERON:0000468" ],
      "Species" : [ "taxonomy:9606" ],
      "CellType" : [ "cl:CL:0000623" ]
    }
  },
  "verbose_text" : "Because KIR3DL2 is highly expressed on cutaneous T cell lymphomas, including mycosis fungoides and Sezary syndrome, IPH4102 has been developed for the treatment of these diseases.",
  "reading_complete" : "2020-08-04T11:10:34Z",
  "reader_type" : "machine",
  "reading_started" : "2020-08-04T11:05:52Z",
  "trigger" : "expressed",
  "evidence" : [ "KIR3DL2 is highly expressed" ],
  "pmc_id" : "6558367",
  "score" : 0
}